Literature DB >> 15326127

Glutamate-induced glutamine synthetase expression in retinal Muller cells after short-term ocular hypertension in the rat.

Fran Shen1, Bin Chen, John Danias, Kevin C Lee, Hokyung Lee, Yanling Su, Steven M Podos, Thom W Mittag.   

Abstract

PURPOSE: To determine the effect of intraocular pressure (IOP) elevation on glutamate-induced expression of glutamine synthetase (GS) in retinal Müller cells of rat eyes.
METHODS: Six groups of three rats each were studied. Group I was a normal control group. In Group II, one eye received an intravitreal glutamate injection (75 nmoles) while the contralateral eye served as control. In Groups III and IV, IOP was raised in one eye by episcleral vein cauterization. Moderately elevated IOP was maintained for 1 day in Group III or 1 week in Group IV (35 +/- 1.9-45 +/- 5.2 mm Hg). An additional two groups of rats received bilateral intravitreal glutamate injections (75 nmoles) immediately (Group V), or 6 days (Group VI), after induction of IOP elevation in one eye. One day after glutamate injection the rats in all groups were killed, and the eyes enucleated and fixed. Retinas from left and right eyes of each animal were embedded together in LR White resin (Ted Pella, Redding, CA). Sections were processed for GS immunolabeling with antibodies to GS by two-stage immunogold labeling with silver enhancement. Images of labeled retinas from the two eyes were captured under identical light microscopic conditions and the GS immunoreactivity in Müller cells was compared between the left and right retinas in the same section by image analysis. An additional five rats were included in Group II and the retinas were analyzed by Western blot analysis to confirm immunohistochemical findings.
RESULTS: Similar to the finding in the control group (Group I), the GS immunoreactivity of the left and right eyes of Group III and IV remained unchanged even though the right eyes in the two groups had elevation of IOP lasting for 24 hours and 1 week, respectively. However, GS levels were significantly increased by 40 +/- 5.7% in normotensive eyes 24 hours after intravitreal injection of glutamate (Group II). The rise in GS immunoreactivity was abolished in eyes with acute IOP elevation (Group V). In contrast, when the eyes were exposed to high IOP for 1 week (Group VI), the glutamate-induced increase in GS immunoreactivity was restored.
CONCLUSIONS: Elevated levels of vitreal glutamate can increase the expression of GS in retinal Müller cells. This increase was blocked if IOP was acutely elevated for 24 hours but was restored if IOP remained elevated for 1 week. This finding suggests that moderate elevation of IOP causes only short-term functional changes of glutamate metabolism (amidation) by retinal Müller cells. However, it is not known to what extent endogenous extracellular glutamate can regulate GS expression in normal eyes or in eyes with glaucoma. Copyright Association for Research in Vision and Ophthalmology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326127     DOI: 10.1167/iovs.03-0948

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

1.  Effects of acutely elevated hydrostatic pressure in a rat ex vivo retinal preparation.

Authors:  Makoto Ishikawa; Takeshi Yoshitomi; Charles F Zorumski; Yukitoshi Izumi
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-04       Impact factor: 4.799

2.  Altered expression of nNOS/NIDD in the retina of a glaucoma model of DBA/2J mice and the intervention by nNOS inhibition.

Authors:  Chen Chen; Yue Xu; Jindi Zhang; Juming Zhu; Junfang Zhang; Nan Hu; Huaijin Guan
Journal:  J Mol Neurosci       Date:  2013-01-09       Impact factor: 3.444

3.  Effect of high hydrostatic pressure on the expression of glutamine synthetase in rat retinal Müller cells cultured in vitro.

Authors:  Jun Yu; Yisheng Zhong; Yu Cheng; Xi Shen; Jun Wang; Yiyong Wei
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

4.  Immunohistochemical Localization of GFAP and Glutamate Regulatory Proteins in Chick Retina and Their Levels of Expressions in Altered Photoperiods.

Authors:  Kumar Abhiram Jha; Tapas C Nag; Shashi Wadhwa; Tara Sankar Roy
Journal:  Cell Mol Neurobiol       Date:  2016-11-04       Impact factor: 5.046

5.  Defective formation of the inner limiting membrane in laminin beta2- and gamma3-null mice produces retinal dysplasia.

Authors:  Germán Pinzón-Duarte; Gerard Daly; Yong N Li; Manuel Koch; William J Brunken
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-11       Impact factor: 4.799

6.  Effect of A(2A) receptor antagonist (SCH 442416) on the mRNA expression of glutamate aspartate transporter and glutamine synthetase in rat retinal Müller cells under hypoxic conditions in vitro.

Authors:  Jun Yu; Xin Huang; Qirong Wu; Jun Wang; Xiaoyan Yu; Peiquan Zhao
Journal:  Exp Ther Med       Date:  2012-02-13       Impact factor: 2.447

7.  Withdrawal from free-choice ethanol consumption results in increased packing density of glutamine synthetase-immunoreactive astrocytes in the prelimbic cortex of alcohol-preferring rats.

Authors:  José Javier Miguel-Hidalgo
Journal:  Alcohol Alcohol       Date:  2006-02-16       Impact factor: 2.826

8.  Stressor-dependent Alterations in Glycoprotein 130: Implications for Glial Cell Reactivity, Cytokine Signaling and Ganglion Cell Health in Glaucoma.

Authors:  Fd Echevarria; Cc Walker; Sk Abella; M Won; Rm Sappington
Journal:  J Clin Exp Ophthalmol       Date:  2013-06-30

9.  Oxidant/antioxidant balance in the aqueous humor of patients with glaucoma.

Authors:  Esra Ergan; Faruk Ozturk; Emrullah Beyazyildiz; Ufuk Elgin; Emine Sen; Ali Bulent Cankaya; Tugrul Celik
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

10.  Immunohistochemical localization of galectin-3 in the pig retina during postnatal development.

Authors:  Jihoon Kim; Changjong Moon; Meejung Ahn; Hong-Gu Joo; Jae-Kwang Jin; Taekyun Shin
Journal:  Mol Vis       Date:  2009-09-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.